Registry of Asthma Patients Initiating DUPIXENT®
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis
- Status
- COMPLETED
- Phase
- N/A
Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment
- Status
- RECRUITING
- Phase
- N/A
Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate Cancer
- Status
- UNKNOWN
- Phase
- NA
Investigating Novel Predictions of Hypoglycemia Occurrence in Real-world Models
- Status
- COMPLETED
- Phase
- N/A
Best Practice Study of Diabetes Type 2 Management in Primary Care in Switzerland
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
ATG Plus PTCy vs ATG for CGVHD Prophylaxis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)
- Status
- COMPLETED
- Phase
- PHASE3
Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Complement Activation in the Lysosomal Storage Disorders
- Status
- WITHDRAWN
- Phase
- N/A
PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)
- Status
- COMPLETED
- Phase
- PHASE3
Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)
- Status
- COMPLETED
- Phase
- PHASE3
Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy
- Status
- COMPLETED
- Phase
- N/A
Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE3
Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
To Assess the Glycosphingolipid Clearance and Clinical Effects of Switching to Agalsidase Beta (Fabrazyme) Versus Continuing on Agalsidase Alfa (Replagal) in Male Patients With Classic Fabry Disease
- Status
- WITHDRAWN
- Phase
- PHASE4